Blood Screening by Nucleic Acid Amplification Technology: Current Issues, Future Challenges-Reference-Cited by-同舟云学术

Blood Screening by Nucleic Acid Amplification Technology: Current Issues, Future Challenges

Published:2000-03 Issue:1 Volume:5 Page:11-22
ISSN:1084-8592
Container-title:Molecular Diagnosis
language:en
Short-container-title:Molecular Diagnosis

Author:

Gallarda James L.,Dragon Elizabeth

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/BF03262018.pdf

Reference44 articles.

1. Centers for Disease Control: Update on acquired immunodeficiency syndrome (AIDS) among patients with hemophilia A. Morb Mortal Wkly Rep 1982; 31: 644-651

2. Beeson PB: Jaundice occurring one to four months after transfusion of blood or plasma. Report of seven cases. JAMA 1943;121: 1332–1334

3. Hewlett IK, Epstein JS: Food and Drug Administration conference on the feasibility of genetic technology to close the HIV window in donor screening (conference report). Transfusion 1997;37: 346–351

4. Gallarda JL, Henrard DR, Liu D, et al.: Early detection of antibody to human immunodeficiency virus type 1 by an antigen conjugate immunoassay correlates with the presence of IgM antibody. sJ Clin Microbiol 1992;30: 770–772

5. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donors Study. N Engl J Med 1996;334: 1685–1690

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and clinical validation of a one-step pentaplex real-time reverse transcription PCR assay for detection of hepatitis virus B, C, E, Treponema pallidum, and a human housekeeping gene;BMC Infectious Diseases;2023-05-25